糖尿病黄斑水肿（DME）治疗存在挑战，为探究其治疗效果，研究人员用扫频源（SS）OCT 和 OCT 血管造影（SS-OCTA）分析治疗初治患者。结果显示多种生物标志物改善，还发现脉络膜厚度分层与治疗反应有关，为个性化治疗提供依据。

DIAMOND is the first and only pivotal trial program ever conducted with a topical treatment for diabetic macular edema (DME) Over 800 patients randomized in DIAMOND-1 or DIAMOND-2 Phase 3 trials at an ...

Rapid completion of enrollment in the DIAMOND (DIAbetic Macular edema patients ON a Drop) program, consisting of two (2) Phase 3, double-masked, randomized, multi-center trials to evaluate the ...

The trials enrolled over 800 patients at 119 investigative sites throughout the United States and several other countries. Rapid completion of enrollment in the DIAMOND (DIAbetic Macular edema ...

DIAMOND is the first and only pivotal trial program ever conducted with a topical treatment for diabetic macular edema (DME) Over 800 patients randomized in DIAMOND-1 or DIAMOND-2 Phase 3 trials ...

Macular edema in many cases can be seen just by looking at your macula with a slit lamp microscope. However, more subtle conditions are difficult to see. In these cases, an optical coherence ...

Purpose To use optical coherence tomography angiography (OCTA) parameters from both the retinal and choroidal microvasculature to detect the presence and severity of diabetic retinopathy (DR). Method ...

According to a panel of 11 United States-based expert eye care professionals (ECPs; including optometrists, general ophthalmologists and retina specialists), OCT is the preferred imaging method ...

Faricimab can reduce the treatment burden in managing macular edema secondary to retinal vein occlusion. Faricimab has sustained efficacy, and can result in gains in best-corrected visual acuity (BCVA ...